Valuation: PeptiDream Inc.

Market Cap 132B 833M 715M 667M 612M 1.15B 79.63B 1.17B 7.87B 3.08B 39.94B 3.13B 3.06B P/E 2026 *
10.4x
P/E 2027 * 10.6x
Enterprise Value 102B 646M 554M 517M 475M 893M 61.74B 907M 6.1B 2.39B 30.96B 2.43B 2.37B EV / Sales 2026 *
2.3x
EV / Sales 2027 * 2.02x
Free-Float
72.4%
Yield 2026 *
-
Yield 2027 * 0.39%
1 day+0.15%
1 week+3.51%
Current month+8.42%
1 month+5.34%
3 months-8.22%
6 months-26.01%
Current year-38.00%
1 week 972.5
Extreme 972.5
1,073
1 month 906.4
Extreme 906.4
1,073
Current year 906.4
Extreme 906.4
1,788
1 year 906.4
Extreme 906.4
1,818.5
3 years 906.4
Extreme 906.4
3,060
5 years 906.4
Extreme 906.4
4,140
10 years 906.4
Extreme 906.4
6,540
Manager TitleAgeSince
Chief Executive Officer 51 2021-12-31
Chief Operating Officer - 2026-07-01
Chief Tech/Sci/R&D Officer - 2024-03-31
Director TitleAgeSince
Director/Board Member 51 2008-07-31
Director/Board Member 51 2017-08-31
Director/Board Member 55 2021-02-28
Change 5-day change 1-year change 3-year change Capi.($)
+0.15%+3.51%-32.90%-40.65% 826M
-1.90%+2.37%+69.11%+110.88% 73.45B
+0.87%+17.17%+53.05%+95.59% 62.99B
+1.71%-1.44%+2.66%+501.29% 28.05B
-1.40%+4.18%+54.52%+19.60% 25.42B
+21.96%+21.90%+0.51%+2.50% 23.3B
+2.28%+7.98%+42.75%-12.34% 19.45B
0.00%-4.11%+243.99%+423.83% 18.16B
-3.50%-0.95%+17.17%+534.55% 16.53B
+2.39%+5.96%+44.04%+157.77% 13.16B
Average +2.26%+2.80%+49.49%+179.30% 28.14B
Weighted average by Cap. +1.63%+4.38%+56.83%+167.49%

Financials

2026 *2027 *
Net sales 44.47B 281M 241M 225M 206M 388M 26.81B 394M 2.65B 1.04B 13.45B 1.05B 1.03B 45.74B 289M 248M 231M 212M 399M 27.58B 405M 2.73B 1.07B 13.83B 1.08B 1.06B
Net income 12.77B 80.56M 69.1M 64.53M 59.2M 111M 7.7B 113M 761M 298M 3.86B 302M 296M 12.55B 79.18M 67.92M 63.42M 58.19M 109M 7.57B 111M 748M 293M 3.8B 297M 291M
Net Debt -29.66B -187M -161M -150M -138M -259M -17.89B -263M -1.77B -693M -8.97B -703M -687M -39.87B -252M -216M -201M -185M -348M -24.04B -353M -2.38B -931M -12.06B -945M -924M
Logo PeptiDream Inc.
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Employees
645
Date Price Change Volume
26-08-19 JP¥1,027.00 +0.15% 957,400
26-08-18 JP¥1,025.50 +2.29% 1,416,800
26-08-17 JP¥1,002.50 -2.81% 1,431,900
26-08-14 JP¥1,031.50 -1.39% 1,484,800
26-08-13 JP¥1,046.00 +3.87% 2,206,800
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,027.00JPY
Average target price
2,725.00JPY
Spread / Average Target
+165.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4587 Stock